MAY 27·SEC EDGARLow
BOBO DONALD E JR sold $2.0M of EW
BOBO DONALD E JR (CVP,Strategy/Corp Development) sold 23,145 shares of Edwards Lifesciences Corp (EW) at $86.42 ($2.00M total) on 2026-05-27.
StockHealthcare · Medical Devices
$EW
Edwards Lifesciences Corp
Price · $EWvia TradingView
AI sentiment · 7d2 articles
- Bullish
- 1
- Neutral
- 1
- Bearish
- 0
Top stories · $EWMore →
MAY 23·MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Rathbones Group PLC
Rathbones Group PLC significantly decreased its stake in Edwards Lifesciences (NYSE:EW) by 81% in the fourth quarter, selling 71,276 shares and retaining 16,695 shares valued at $1.42 million. Despite this, other institutional investors like Vanguard Group Inc. and Wellington Management Group LLP increased their positions. Edwards Lifesciences reported strong Q1 earnings, beating analyst estimates with $0.78 EPS and $1.65 billion in revenue, and analysts maintain a "Moderate Buy" rating with a consensus price target of $95.65.
MAY 20·Simply Wall Street
How Investors May Respond To Becton Dickinson (BDX) Loss, Recall And New Interventional Leadership
Becton, Dickinson and Company (BDX) reported a Q2 net loss of US$311 million despite sales of US$4,714 million, while also affirming full-year GAAP revenue growth guidance and appointing Peter Menziuso to lead BD Interventional. The company's investment narrative now focuses on executing in higher growth franchises like BD Interventional and addressing regulatory and quality pressures highlighted by a recent microbiology pouch recall. Despite these challenges, an expanded infection-prevention partnership and solid operational growth initiatives aim to stabilize earnings, though investors are urged to consider the impact of ongoing quality scrutiny on long-term growth.